focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
6 Apr 2021 08:37

Clinigen to launch 'Erwinase' in the UK earlier than planned

(Sharecast News) - Pharmaceutical products and services company Clinigen Group announced on Tuesday that it will be providing access to 'Erwinase', or L-asparaginase Erwinia chrysanthemi, in the UK from 6 April.

Read more
24 Mar 2021 14:38

EXECUTIVE CHANGES: Experian appoints Sage Group CFO as non-executive

EXECUTIVE CHANGES: Experian appoints Sage Group CFO as non-executive

Read more
11 Mar 2021 16:10

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
5 Mar 2021 13:07

Friday broker round-up

(Sharecast News) - Aggreko: Peel Hunt upgrades to hold with a target price of 880p.

Read more
23 Feb 2021 13:39

Tuesday broker round-up

(Sharecast News) - Clinigen: Liberum reiterates buy with a target price of 1,050p.

Read more
23 Feb 2021 09:35

Clinigen Maintains Interim Payout And Expects Revenue Growth In Year

Clinigen Maintains Interim Payout And Expects Revenue Growth In Year

Read more
16 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Feb 2021 10:07

Clinigen Simplifies Structure, Moves To Two Reporting Units From Three

Clinigen Simplifies Structure, Moves To Two Reporting Units From Three

Read more
1 Feb 2021 13:44

Monday broker round-up

(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.

Read more
14 Jan 2021 12:09

IN BRIEF: Clinigen Expects Drop In Interim Earnings Despite Revenue

IN BRIEF: Clinigen Expects Drop In Interim Earnings Despite Revenue

Read more
4 Jan 2021 09:56

Clinigen Appoints Former World Courier President As Operating Chief

Clinigen Appoints Former World Courier President As Operating Chief

Read more
26 Nov 2020 10:45

Clinigen Trading In Line With Expectations, Reiterates Guidance

Clinigen Trading In Line With Expectations, Reiterates Guidance

Read more
26 Nov 2020 09:18

Clinigen trades in line despite ongoing Covid-19 impact

(Sharecast News) - Pharmaceutical and services company Clinigen said on Thursday that trading had been in-line with market expectations despite the ongoing impact of the Covid-19 pandemic.

Read more
25 Nov 2020 16:03

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
25 Nov 2020 09:28

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.